Department of Otorhinolaryngology, University of Insubria, Varese, Italy.
Otolaryngol Head Neck Surg. 2014 Apr;150(4):696-702. doi: 10.1177/0194599813520290. Epub 2014 Jan 23.
To describe the endoscopic transnasal approach to the infratemporal fossa (ITF) and upper parapharyngeal space (UPS) and to analyze the indications and outcomes of this surgical technique in the management of the tumors localized in this critical area.
Case series with chart review.
Tertiary-care referral center.
Retrospective review of patients with benign and malignant tumors arising in or extending to the ITF and UPS, treated from 2002 to 2012 at a single institute. The tumors were surgically resected using an endoscopic endonasal transpterygoid transmaxillary approach.
Thirty-seven consecutive patients with benign tumors (20 juvenile nasopharyngeal angiofibromas, 2 extracranial trigeminal Schwannomas, 2 meningiomas, 1 cavernous hemangioma) and nonmetastatic malignant tumors (2 adenoid-cystic carcinoma, 1 mucoepidermoid carcinoma, 1 squamous cell carcinoma, 1 adenocarcinoma, 1 recurrence of chondrosarcoma, and 6 recurrences of undifferentiated carcinoma of nasopharyngeal type) were treated with curative intent. A gross-total resection was achieved in 35 of 37 patients. Major complications were observed in 1 case (intraoperative internal carotid artery blowout). Postoperatively, 8 patients received some form of adjuvant treatment. Mean follow-up was 30 months for malignancies and 60 months for benign tumors. All patients are now alive without recurrences. Stable intracranial persistence of disease was reported in 2 cases (1 meningioma and 1 adenoid-cystic carcinoma).
The purely endoscopic endonasal technique may provide a minimally invasive and safe approach to radically resect selected tumors involving the ITF and UPS. Larger case series and longer follow-up are needed to validate the reproducibility and efficacy of this technique.
描述经鼻内镜入路至颞下窝(ITF)和咽旁上间隙(UPS)的方法,并分析该手术技术在治疗位于该关键区域的肿瘤中的适应证和结果。
病例系列和图表回顾。
三级转诊中心。
回顾性分析 2002 年至 2012 年在一家机构接受治疗的起源于 ITF 和 UPS 或向其扩展的良性和恶性肿瘤患者。使用经鼻内镜经翼突经上颌入路切除肿瘤。
37 例连续患者(20 例青少年鼻咽血管纤维瘤、2 例颅外三叉神经施万细胞瘤、2 例脑膜瘤、1 例海绵状血管瘤)和非转移性恶性肿瘤(2 例腺样囊性癌、1 例黏液表皮样癌、1 例鳞状细胞癌、1 例腺癌、1 例软骨肉瘤复发和 6 例未分化鼻咽癌复发)接受了治愈性治疗。37 例患者中有 35 例实现了大体全切除。1 例(术中颈内动脉破裂)观察到主要并发症。术后 8 例患者接受了某种形式的辅助治疗。恶性肿瘤的平均随访时间为 30 个月,良性肿瘤为 60 个月。所有患者均存活且无复发。2 例(1 例脑膜瘤和 1 例腺样囊性癌)报告颅内疾病稳定持续。
单纯经鼻内镜技术可为根治性切除涉及 ITF 和 UPS 的选定肿瘤提供微创和安全的方法。需要更大的病例系列和更长的随访时间来验证该技术的可重复性和疗效。